Global Immuno Oncology Market Research Report 2023(Status and Outlook)

Global Immuno Oncology Market Research Report 2023(Status and Outlook)



Report Overview

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The Global Immuno Oncology Market Size was estimated at USD 43650.00 million in 2022 and is projected to reach USD 115404.95 million by 2029, exhibiting a CAGR of 14.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Immuno Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno Oncology market in any manner.

Global Immuno Oncology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bristol-Myers Squibb

Merck & Co., Inc.

Roche AG

AstraZeneca, Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

Merck KGaA

Market Segmentation (by Type)

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Others

Immuno-

Market Segmentation (by Application)

Automotive

Aviation & Marine

Heavy Machinery

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Immuno Oncology Market

Overview of the regional outlook of the Immuno Oncology Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno Oncology
1.2 Key Market Segments
1.2.1 Immuno Oncology Segment by Type
1.2.2 Immuno Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno Oncology Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Immuno Oncology Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno Oncology Market Competitive Landscape
3.1 Global Immuno Oncology Sales by Manufacturers (2018-2023)
3.2 Global Immuno Oncology Revenue Market Share by Manufacturers (2018-2023)
3.3 Immuno Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno Oncology Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Immuno Oncology Sales Sites, Area Served, Product Type
3.6 Immuno Oncology Market Competitive Situation and Trends
3.6.1 Immuno Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno Oncology Industry Chain Analysis
4.1 Immuno Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno Oncology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno Oncology Sales Market Share by Type (2018-2023)
6.3 Global Immuno Oncology Market Size Market Share by Type (2018-2023)
6.4 Global Immuno Oncology Price by Type (2018-2023)
7 Immuno Oncology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno Oncology Market Sales by Application (2018-2023)
7.3 Global Immuno Oncology Market Size (M USD) by Application (2018-2023)
7.4 Global Immuno Oncology Sales Growth Rate by Application (2018-2023)
8 Immuno Oncology Market Segmentation by Region
8.1 Global Immuno Oncology Sales by Region
8.1.1 Global Immuno Oncology Sales by Region
8.1.2 Global Immuno Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Immuno Oncology Basic Information
9.1.2 Bristol-Myers Squibb Immuno Oncology Product Overview
9.1.3 Bristol-Myers Squibb Immuno Oncology Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Immuno Oncology SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Merck andamp; Co., Inc.
9.2.1 Merck andamp; Co., Inc. Immuno Oncology Basic Information
9.2.2 Merck andamp; Co., Inc. Immuno Oncology Product Overview
9.2.3 Merck andamp; Co., Inc. Immuno Oncology Product Market Performance
9.2.4 Merck andamp; Co., Inc. Business Overview
9.2.5 Merck andamp; Co., Inc. Immuno Oncology SWOT Analysis
9.2.6 Merck andamp; Co., Inc. Recent Developments
9.3 Roche AG
9.3.1 Roche AG Immuno Oncology Basic Information
9.3.2 Roche AG Immuno Oncology Product Overview
9.3.3 Roche AG Immuno Oncology Product Market Performance
9.3.4 Roche AG Business Overview
9.3.5 Roche AG Immuno Oncology SWOT Analysis
9.3.6 Roche AG Recent Developments
9.4 AstraZeneca, Plc
9.4.1 AstraZeneca, Plc Immuno Oncology Basic Information
9.4.2 AstraZeneca, Plc Immuno Oncology Product Overview
9.4.3 AstraZeneca, Plc Immuno Oncology Product Market Performance
9.4.4 AstraZeneca, Plc Business Overview
9.4.5 AstraZeneca, Plc Immuno Oncology SWOT Analysis
9.4.6 AstraZeneca, Plc Recent Developments
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Immuno Oncology Basic Information
9.5.2 Sanofi S.A. Immuno Oncology Product Overview
9.5.3 Sanofi S.A. Immuno Oncology Product Market Performance
9.5.4 Sanofi S.A. Business Overview
9.5.5 Sanofi S.A. Immuno Oncology SWOT Analysis
9.5.6 Sanofi S.A. Recent Developments
9.6 Dendreon Pharmaceuticals
9.6.1 Dendreon Pharmaceuticals Immuno Oncology Basic Information
9.6.2 Dendreon Pharmaceuticals Immuno Oncology Product Overview
9.6.3 Dendreon Pharmaceuticals Immuno Oncology Product Market Performance
9.6.4 Dendreon Pharmaceuticals Business Overview
9.6.5 Dendreon Pharmaceuticals Recent Developments
9.7 Novartis
9.7.1 Novartis Immuno Oncology Basic Information
9.7.2 Novartis Immuno Oncology Product Overview
9.7.3 Novartis Immuno Oncology Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Gilead Sciences Inc.
9.8.1 Gilead Sciences Inc. Immuno Oncology Basic Information
9.8.2 Gilead Sciences Inc. Immuno Oncology Product Overview
9.8.3 Gilead Sciences Inc. Immuno Oncology Product Market Performance
9.8.4 Gilead Sciences Inc. Business Overview
9.8.5 Gilead Sciences Inc. Recent Developments
9.9 Merck KGaA
9.9.1 Merck KGaA Immuno Oncology Basic Information
9.9.2 Merck KGaA Immuno Oncology Product Overview
9.9.3 Merck KGaA Immuno Oncology Product Market Performance
9.9.4 Merck KGaA Business Overview
9.9.5 Merck KGaA Recent Developments
10 Immuno Oncology Market Forecast by Region
10.1 Global Immuno Oncology Market Size Forecast
10.2 Global Immuno Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Immuno Oncology Market Size Forecast by Region
10.2.4 South America Immuno Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno Oncology by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Immuno Oncology Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Immuno Oncology by Type (2024-2029)
11.1.2 Global Immuno Oncology Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Immuno Oncology by Type (2024-2029)
11.2 Global Immuno Oncology Market Forecast by Application (2024-2029)
11.2.1 Global Immuno Oncology Sales (K Units) Forecast by Application
11.2.2 Global Immuno Oncology Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings